Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
Due to its powerful effects, the medication is started at a low dose to help the body adapt and reduce the risk of gastrointestinal side effects
Est enriquecida con vitaminas: Vitamina B1, promueve la funcin normal del corazn mientras las vitaminas B3, B5, B6 contribuyen a la reduccin de la fatiga y el cansancio y a los mecanismos normales de la energa
Promotes muscular energy Supports exercise recovery Plays an essential role in making fatty acids available for muscle tissue Suggested Use Take one (1) tablespoon (15 ml) 30-60 minutes before exercise with your pre-workout meal and/or your post-workout meal
The emphasis on obesity medicine specialization means that providers are typically well-versed in the nuances of GLP-1 therapy, including side effect management, dose improvement, and addressing plateaus